Fukuda Denshi Co., Ltd.

Tokyo Stock Exchange 6960.T

Fukuda Denshi Co., Ltd. Receivables for the year ending March 31, 2024: USD 272.07 M

Fukuda Denshi Co., Ltd. Receivables is USD 272.07 M for the year ending March 31, 2024, a -12.04% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Fukuda Denshi Co., Ltd. Receivables for the year ending March 31, 2023 was USD 309.32 M, a -4.50% change year over year.
Fukuda Denshi Co., Ltd. Receivables for the year ending March 31, 2022 was USD 323.89 M, a -21.86% change year over year.
Fukuda Denshi Co., Ltd. Receivables for the year ending March 31, 2021 was USD 414.50 M, a 17.26% change year over year.
Fukuda Denshi Co., Ltd. Receivables for the year ending March 31, 2020 was USD 353.49 M, a 1.27% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

Tokyo Stock Exchange: 6960.T

Fukuda Denshi Co., Ltd.

CEO	Mr. Kotaro Fukuda
IPO Date	Jan. 4, 2000
Location	Japan
Headquarters	2-35-8 Hongo
Employees	3,443
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Fukuda Denshi Co., Ltd. engages in manufacture and sale of medical instruments in Japan and internationally. It offers resting electrocardiograph products; data management software; stress test products; and patient monitoring systems, including central and bedside monitors, transmitters, and central viewer workstations; and vascular screening systems. The company was founded in 1939 and is based in Tokyo, Japan.

Key trends

Past 5 years